SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-14-002410
Filing Date
2014-08-08
Accepted
2014-08-08 16:15:57
Documents
4
Period of Report
2014-08-08
Effectiveness Date
2014-08-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a.htm DEF 14A 447246
2 GRAPHIC logo1.jpg GRAPHIC 19918
3 GRAPHIC logo2.jpg GRAPHIC 69932
4 GRAPHIC logo3.jpg GRAPHIC 120349
  Complete submission text file 0001493152-14-002410.txt   738527
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35814 | Film No.: 141027662
SIC: 2834 Pharmaceutical Preparations